Quantification of murine pancreatic tumors by high-resolution ultrasound.
暂无分享,去创建一个
[1] Drew A. Torigian,et al. CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans , 2011, Science.
[2] Mallika Singh,et al. Assessing therapeutic responses in Kras mutant cancers using genetically engineered mouse models , 2010, Nature Biotechnology.
[3] David Allard,et al. Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer , 2009, Science.
[4] R. Hruban,et al. Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. , 2005, Cancer cell.
[5] R. Hruban,et al. Tumor-suppressor genes in pancreatic cancer. , 1998, Journal of hepato-biliary-pancreatic surgery.
[6] S. Goodman,et al. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. , 1993, The American journal of pathology.
[7] D. Tuveson,et al. K-Ras-driven pancreatic cancer mouse model for anticancer inhibitor analyses. , 2008, Methods in enzymology.
[8] E. Furth,et al. Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations. , 2006, Cancer research.
[9] Vincristine , 2003 .